Document is current

Any future updates will be listed below

Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer

Crossref DOI link: https://doi.org/10.1038/s41598-024-73222-0

Published Online: 2024-11-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark